SPX3,744.52-38.76 -1.02%
DIA299.23-3.56 -1.18%
IXIC11,073.31-75.33 -0.68%

Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session.

Benzinga · 09/13/2022 11:30


U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session.

  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) surged 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
  • Akero Therapeutics, Inc. (NASDAQ:AKRO) shares gained 111% to $25.88 after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
  • VNET Group, Inc. (NASDAQ:VNET) jumped 30.7% to $6.13 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
  • Planet Labs PBC (NYSE:PL) rose 15.1% to $6.24 after the company reported better-than-expected Q2 results and raised guidance.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) gained 13.3% to $17.16. S&P Dow Jones Indices said Catalyst Pharmaceuticals will replace Mantech International Corp. in S&P Smallcap 600 on September 15.
  • Aehr Test Systems (NASDAQ:AEHR) rose 11.4% to $15.70 after the company received a wafer level burn-in system order.
  • Celularity Inc. (NASDAQ:CELU) rose 11.3% to $2.6050.
  • Entrada Therapeutics, Inc. (NASDAQ:TRDA) jumped 8.3% to $12.90. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • LSB Industries, Inc. (NYSE:LXU) gained 6.9% to $17.13. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
  • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) jumped 5.9% to $6.98. Truist Securities maintained Concert Pharma with a Buy and raised the price target from $22 to $25.
  • Li Auto Inc. (NASDAQ:LI) gained 4.2% to $27.14.
  • Core & Main, Inc. (NYSE:CNM) rose 3.7% to $25.40 following upbeat Q2 results.